Potential Role Of Curcumin Phytosome (Meriva) In Controlling The Evolution Of Diabetic Microangiopathy. A Pilot Study
Notes for this study:
|Number of Subjects
1g of curcumin (Meriva; enhanced bioavailability) was taken in two divided dosages of 500mg in 25 diabetic patients without insulin therapy; an improvement in microangiopathic symptoms was seen as well as a reduction in edema associated with diabetes over a period of 4 weeks.
Microangiopathy recorded as 'blood flow', although only specific to small vessels.